Clinical Trial

Registry on Percutaneous Electrochemotherapy

Study acronym: RESPECT
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The Registry on Percutaneous ElectroChemoTherapy (RESPECT) is a post-market, prospective, non-randomized, observational study aiming at evaluating the effectiveness of percutaneous electrochemotherapy (ECT) for the treatment of liver cancer.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2022-02-23; most recent amendment 2026-02-04.
Status change: Recruiting → Active, Not Recruiting 2026-02-04
Status change: Not Yet Recruiting → Recruiting 2023-05-04
Trial Details
NCT Number NCT05267080
Lead Sponsor Cardiovascular and Interventional Radiological Society of Europe
Conditions Primary Liver Cancer, Secondary Liver Cancer
Enrollment 250 participants
Start Date 2023-01-25
Primary Completion 2026-01-23 (estimated)
Study Completion 2027-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-06